From: NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands
Pct of patients
PDC* > =80
Nr of patients
Apixaban
92%
7094
Dabigatran
88%
11,782
Rivaroxaban
13,975
Total
89%
32,851